IMMUNOGENIC COMPOSITION

The present application relates to immunogenic compositions comprising Type 5 and/or 8 capular polysaccharide or oligosaccharide from S. aureus having between 30-100% O-acetylation. Vaccines, methods of treatment using and processes to make an immunogenic composition comprising Type 5 and/or 8 capsu...

Full description

Saved in:
Bibliographic Details
Main Authors DENOEL, Philippe, Poolman, Jan
Format Patent
LanguageEnglish
Published 19.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present application relates to immunogenic compositions comprising Type 5 and/or 8 capular polysaccharide or oligosaccharide from S. aureus having between 30-100% O-acetylation. Vaccines, methods of treatment using and processes to make an immunogenic composition comprising Type 5 and/or 8 capsular polysaccharides with 30-100% O-acetylation are also described.
Bibliography:Application Number: US201715840527